About Eta Diagnostics
Eta Diagnostics was a Healthcare company based in Albuquerque (United States) founded in 2013. A pre-revenue startup focused on developing high-throughput flow cytometry for commercialization. It operates on a B2B model. Eta Diagnostics has raised $300 thousand across 2 funding rounds from investors including HHS. The company is recorded as dissolved. Its focus areas include Biotechnology, Diagnostics and Flow Cytometry.
Company details
Eta Diagnostics a pre-revenue startup focused on developing high-throughput flow cytometry for commercialization through providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and flow cytometry. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
- Headquarters Albuquerque, United States
- SectorsHealthcare
- Website etadiagnostics.com
- Social Facebook
- Total Equity Funding$300K (USD)
in 2 rounds
- Latest Funding Round$991.77K (USD), Grant
Jun 2016
- Investors
Funding Insights of Eta Diagnostics
Eta Diagnostics has successfully raised a total of $300K across 2 strategic funding rounds. The most recent funding activity was a Grant round of $991.77 thousand completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $300,000
- Total Rounds 2
- Last Round Grant — $991,773
- First Round $300,000
(Dec 2014)
- Investors Count 1
All 2 funding rounds of Eta Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2016 | $991,773 | Grant | – | – | |
| Dec 2014 | $300,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Eta Diagnostics
Eta Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Eta Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Eta Diagnostics
3 dated milestones of Eta Diagnostics across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Eta Diagnostics is founded.
- Funding First funding round of $300K.
- Funding Latest funding round, Grant, of $992K.
Top companies in Hematology
3 companies that operate in the same segment as Eta Diagnostics (Hematology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | 384 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Eta Diagnostics
Eta Diagnostics was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Eta Diagnostics is headquartered in Albuquerque, United States. It is registered at Albuquerque, New Mexico, United States.
Eta Diagnostics is a funded company, having raised a total of $300K across 2 funding rounds to date. The company's 1st funding round was a Seed of $300K, raised on Dec 2014.
Eta Diagnostics a pre-revenue startup focused on developing high-throughput flow cytometry for commercialization through providing healthcare solutions, advancing biotech innovations, offering diagnostic solutions, and flow cytometry. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field.
Eta Diagnostics has 1 investor. Key investors include HHS.